Top CBD companies experience market share drop as online sales soften
The largest CBD companies in the U.S. experienced declining market share in the second quarter, as the return…
News August 31
Latest In: Epidyolex
GW Pharmaceuticals cannabis drug gets regulatory OK in Australia
GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in…
News September 24
UK down-schedules Epidyolex to lowest level for controlled drugs
The United Kingdom has down-scheduled Epidyolex to the lowest level of control for drugs, greatly easing restrictions on…
News June 24
Sponsored
The Next Competitive Advantage in Medical Cannabis Is Clarity
As telehealth simplifies access where permitted, providers are discovering that the real differentiator is helping patients understand what happens before, during, and after certification.
June 30
European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says
The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In…
News September 23Featured
1
Latest Sponsored
